Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population

被引:8
|
作者
Tung, Min-Che [1 ,2 ]
Wen, Yu-Ching [3 ,4 ]
Wang, Shian-Shiang [5 ,6 ,7 ]
Lin, Yung-Wei [3 ,4 ]
Liu, Yu-Cheng [1 ,2 ]
Yang, Shun-Fa [7 ,8 ]
Chien, Ming-Hsien [1 ,9 ]
机构
[1] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[2] TungsTaichung Metro Harbor Hosp, Dept Surg, Taichung, Taiwan
[3] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan
[4] Taipei Med Univ, Coll Med, Sch Med, Dept Urol, Taipei, Taiwan
[5] Taichung Vet Gen Hosp, Dept Surg, Div Urol, Taichung, Taiwan
[6] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[7] Chung Shan Med Univ, Inst Med, 110 Chien Kuo N Rd,Sect 1, Taichung 402, Taiwan
[8] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[9] Taipei Med Univ, Wan Fang Hosp, Dept Med Educ & Res, Taipei, Taiwan
来源
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2018年 / 15卷 / 11期
关键词
Dopamine receptor D2 gene; Polymorphism; Susceptibility; Clinicopathologic development; Urothelial cell carcinoma; BLADDER-CANCER; POLYMORPHISMS; DRD2; IDENTIFICATION; METAANALYSIS; RECURRENCE; MUTATIONS; SMOKING; BINDING;
D O I
10.7150/ijms.26895
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dopamine receptor D2 (DRD2) is overexpressed in several kinds of cancers and was correlated with the prognosis of these cancers. Polymorphisms within the DRD2 gene were shown to be associated with lung and colon cancers. The purpose of this study was to explore effects of DRD2 gene polymorphisms on the susceptibility to and clinicopathological characteristics of urothelial cell carcinoma (UCC). In total, 369 patients diagnosed with UCC and 738 healthy controls were enrolled to analyze DRD2 genotypes at four loci (rs1799732, -141C>del; rs1079597, TaqIB; rs6277, 957C>T; and rs1800497, TaqIA) using a TaqMan-based real-time polymerase chain reaction (PCR). We found a significantly lower risk for UCC in individuals with the DRD2 rs6277 CT genotype compared to those with the wild-type CC genotype (adjusted odds ratio (AOR)=0.405, 95% confidence interval (CI): 0.196 similar to 0.837, p=0.015). In 124 younger patients (aged < 65 years) of the recruited UCC cohort, patients who carried at least one T allele of DRD2 rs1800497 were at higher risk (AOR=2.270, 95% CI: 1.060 similar to 4.860, p=0.033) of developing an invasive stage (pT2 similar to pT4). In 128 female patients of the recruited UCC cohort, patients who carried at least one deletion allele of DRD2 rs1799732 showed a higher incidence of having an invasive stage (AOR=2.585, 95% CI: 1.066 similar to 6.264, p=0.032) and a large tumor (AOR=2.778, 95% CI: 1.146 similar to 6.735, p=0.021). Further analyses of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets revealed correlations of the expression of DRD2 with an invasive tumor, tumor metastasis, and the lower survival rate in patients with UCC. Our findings suggest that DRD2 levels might affect the progression of UCC, and the polymorphisms rs6277, rs1800497, and rs1799732 of DRD2 are probably associated with the susceptibility and clinicopathologic development of UCC in a Taiwanese population.
引用
收藏
页码:1187 / 1193
页数:7
相关论文
共 50 条
  • [1] Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma
    Lin, Yung-Wei
    Wang, Shian-Shiang
    Wen, Yu-Ching
    Tung, Min-Che
    Lee, Liang-Ming
    Yang, Shun-Fa
    Chien, Ming-Hsien
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, 14 (11): : 1130 - 1135
  • [2] Genetic variations at the dopamine D2 receptor locus in Korean population
    Nam, YS
    Lee, C
    KOREAN JOURNAL OF GENETICS, 1997, 19 (04): : 289 - 297
  • [3] Dopamine D2 Receptor Gene Polymorphisms Are Associated with Suicide Attempt in the Japanese Population
    Suda, Akira
    Kawanishi, Chiaki
    Kishida, Ikuko
    Sato, Ryoko
    Yamada, Tomoki
    Nakagawa, Makiko
    Hasegawa, Hana
    Kato, Daiji
    Furuno, Taku
    Hirayasu, Yoshio
    NEUROPSYCHOBIOLOGY, 2009, 59 (02) : 130 - 134
  • [4] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Blasiak, Ewa
    Lukasiewicz, Sylwia
    Szafran-Pilch, Kinga
    Dziedzicka-Wasylewska, Marta
    PHARMACOLOGICAL REPORTS, 2017, 69 (02) : 235 - 241
  • [5] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Ewa Błasiak
    Sylwia Łukasiewicz
    Kinga Szafran-Pilch
    Marta Dziedzicka-Wasylewska
    Pharmacological Reports, 2017, 69 : 235 - 241
  • [6] A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate
    Parsons, Michael J.
    Mata, Ignacio
    Beperet, Maria
    Iribarren-Iriso, Fernando
    Arroyo, Barbara
    Sainz, Ricardo
    Arranz, Maria J.
    Kerwin, Robert
    PSYCHIATRIC GENETICS, 2007, 17 (03) : 159 - 163
  • [7] Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis
    Song, Yang
    Wang, Zhi-Yun
    Jin, Yan-Yu
    Guo, Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (09): : 3165 - 3170
  • [8] Genetic diagnostics of functional variants of the human dopamine D2 receptor gene
    Doehring, Alexandra
    Kirchhof, Anja
    Loetsch, Joern
    PSYCHIATRIC GENETICS, 2009, 19 (05) : 259 - 268
  • [9] Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease
    Mickey, Brian J.
    PHARMACOGENOMICS, 2016, 17 (11) : 1207 - 1210
  • [10] Genetic variations in TERC and TERT genes are associated with renal cell carcinoma risk in a Chinese Han population
    Wu, Dapeng
    Zhu, Guodong
    Zeng, Jin
    Song, Wenbin
    Wang, Ke
    Wang, Xinyang
    Guo, Peng
    He, Dalin
    ONCOTARGET, 2017, 8 (44) : 76832 - 76842